To homepage
820К+ patients have got assistance since 2014
50 countries
1,500 clinics
6K+ reviews
3K+ qualified doctors

What's the Cost of Hypertension Diagnosis and Treatment in Republic of Korea?

The price is provided on request
Republic of KoreaTurkeyAustria
LDL Apheresis-from $1,650-
Data verified by Bookimed as of May 2026, based on patient requests and official quotes from 144 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.

Your Benefits and Guarantees with Bookimed

Transparent Prices & Flexible Installments

No hidden fees – just official clinic prices. Pay at the clinic for Hypertension treatment and use a flexible installment plan if needed.

Verified Clinics & Doctors Only

Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hypertension treatment and have the necessary licenses to serve international patients worldwide.

Free 24/7 Assistance

Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hypertension treatment journey.

Why we?

Your personal Bookimed medical coordinator

  • Supports you at every stage
  • Helps choose the right clinic and doctor
  • Ensures quick and convenient access to information

Best Hypertension Treatment Centers in Republic of Korea: 9 Verified Options and Prices

The Bookimed clinic ranking is based on data science algorithms, providing a trusted, transparent, and objective comparison. It takes into account patient demand, review scores (both positive and negative), the frequency of updates to treatment options and prices, response speed, and clinic certifications.
Ewha Womans University Medical Center

Get a Medical Assessment for Hypertension in Republic of Korea: Consult with Experienced Doctors Now

View all Doctors
verified

Oh Dong Joo

50 years of experience

Dr. Oh Dong Joo is a cardiologist. He specializes in coronary artery disease, valvular heart disease, heart failure, hypertension, and atrial fibrillation.

MD and PhD, Korea University. Professor of Cardiology, Korea University. Cardiology Fellow, Emory University. Clinical Instructor, Cornell University.

Leadership: Chairman, Korean Society of Cardiology. President, Korean Society of Interventional Cardiology. President, Korean Chapter of the ACC. Director, Cardiovascular Research Institute, Korea University.

Publications: 386 total. 242 SCI-indexed international papers.

verified

Byung Hee Oh

41 years of experience

Professor Byung-Hee Oh, MD, PhD, is a cardiologist at Incheon Sejong Hospital. He graduated from Seoul National University College of Medicine. He completed training in Internal Medicine and Cardiology at Seoul National University Hospital. His clinical focus includes heart failure, coronary artery disease, hypertension, atrial fibrillation, and preventive cardiology.

He served as Professor of Cardiology at Seoul National University. He also served as Director of a cardiovascular center and Head of the Division of Cardiology. He was President of the Korean Society of Cardiology and led national heart failure and hypertension groups. He has authored hundreds of peer-reviewed publications. He has given invited lectures at major international cardiology conferences and received national honors.

verified

Min Jeong Kim

18 years of experience

Dr. Min-Jeong Kim, MD, PhD, is a cardiologist at Incheon Sejong Hospital. She focuses on interventional cardiology, heart failure, hypertension, and preventive cardiology.

She earned her MD and PhD from Seoul National University College of Medicine. She completed advanced training in internal medicine and cardiovascular disease at a major medical center in Korea.

Her expertise includes coronary artery disease, chronic heart failure, arrhythmias, and hypertension. She performs coronary angiography and percutaneous coronary intervention. She is skilled in diagnostic echocardiography and comprehensive cardiovascular evaluation.

She provides evidence-based care with careful risk assessment and personalized treatment. She works with multidisciplinary cardiac teams to improve prevention and long-term outcomes.

verified

Paik Nam-sun

47 years of experience

The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.

Share this content

Video Stories from Bookimed Patients

Dayana
I combined my vacation in Antalya with a check-up.
Procedure: Female check-up
Igor
It was great! Transfers, accommodation, treatment—all included.
Procedure: Dental Implant
Marina
Bookimed did everything for me. I didn't have to worry about anything.
Procedure: Female check-up
Updated: 05/27/2022
Authored by
Anna Leonova
Anna Leonova
Head of Content Marketing Team
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
Fahad Mawlood
Medical Editor & Data Scientist
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Fahad Mawlood Linkedin
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.

Expert Overview about Hypertension Treatment in Republic of Korea

These FAQs come from real patients seeking medical assistance through Bookimed. Answers are given by experienced medical coordinators and trusted clinic representatives.

What is the standard blood pressure target for treatment in Korea?

The standard blood pressure target in South Korea is less than 140/90 mmHg for most adults. The Korean Society of Hypertension maintains this baseline. High-risk patients with diabetes or cardiovascular disease typically require more intensive control. Experts often aim for targets below 130/80 mmHg in these cases.

  • General population target: Standard clinical goal is less than 140/90 mmHg.
  • High-risk groups: Cardiovascular disease patients target less than 130/80 mmHg.
  • Diabetes management: Usual target is 140/85 mmHg or 130/80 mmHg.
  • Home monitoring: Targets are lower at 135/85 mmHg for general hypertensive patients.

Bookimed Expert Insight: Quality indicators reflect the high standard of cardiology in Seoul. Asan Medical Center performs 45% of Korea's heart transplants and maintains 90% success rates. This volume suggests that clinics with Newsweek rankings often manage the most complex hypertension cases. Look for JCI-accredited centers like Severance Hospital for integrated cardiovascular care.

Patient Consensus: Patients note that Korean care teams strongly emphasize keeping daily home logs. Many report that doctors prioritize tighter control specifically to reduce the risk of stroke.

Which medications are most commonly prescribed for hypertension in Korea?

Hypertension treatment in South Korea primarily utilizes angiotensin receptor blockers (ARB) and calcium channel blockers (CCB). These drug classes cover over 75% and 60% of patients respectively. Local protocols favor these over ACE inhibitors to avoid common side effects like chronic dry cough.

  • Dominant ARBs: Telmisartan and losartan are the most frequently prescribed angiotensin receptor blockers.
  • Leading CCB: Amlodipine remains the primary calcium channel blocker used for blood pressure.
  • Combination therapy: Dual therapy regimens using single-pill combinations apply to 44% of patients.
  • Prescription frequency: Diuretics and beta-blockers serve 22% and 15% of treated cases respectively.

Bookimed Expert Insight: Data from top-tier institutions like Asan Medical Center and Seoul National University Hospital shows a heavy shift toward digitalization. These centers use advanced systems like BESTcare to track long-term medication adherence. This digital focus ensures that patients receiving complex dual therapies are monitored with higher precision than in traditional paper-based systems.

Patient Consensus: Patients note that doctors often start treatment with amlodipine or losartan due to their high availability. While these are effective, many emphasize checking for leg swelling or dizziness, especially when using high-dose combination pills.

Are lifestyle modifications part of Korea’s official hypertension guidelines?

Lifestyle modifications are a central pillar of the official Korean hypertension guidelines. The Korean Society of Hypertension mandates non-drug therapy for all patients. Specific recommendations prioritize sodium reduction to under 6g daily. Clinics implement these changes alongside medication or as a primary first-line treatment phase.

  • Sodium limit: Guidelines restrict daily salt intake to less than 6g total.
  • Dietary patterns: Doctors recommend Korean-style diets high in vegetables, fish, and legumes.
  • Weight targets: Patients aim for a BMI below 25 for optimal pressure control.
  • Treatment timing: Low-risk patients may undergo lifestyle changes for up to 3 months.

Bookimed Expert Insight: While many countries follow Western DASH diets, South Korea's top cardiology centers like Asan Medical Center integrate specialized nutritional counseling to modify high-sodium traditional staples. Our data shows that major Seoul facilities often use 24-hour ambulatory monitoring to verify if lifestyle shifts alone are sufficient before starting lifelong medication protocols.

Patient Consensus: Patients note that doctors strictly emphasize cutting salt from common foods like kimchi and ramyeon. Many recommend pairing these dietary changes with daily 30-minute walks to see significant blood pressure improvements.

Is home blood-pressure monitoring (HBPM) recommended for patients in South Korea?

Home blood-pressure monitoring is strongly recommended in South Korea for hypertension diagnosis and management. The Korean Society of Hypertension advises a 135/85 mmHg threshold for home readings. Using validated automated upper-arm devices helps identify masked hypertension and significantly improves long-term cardiovascular outcomes.

  • Diagnostic threshold: Hypertension is confirmed if home averages reach 135/85 mmHg.
  • Best practices: Measure BP 1–3 times per session twice daily.
  • Optimal timing: Check within 1 hour of waking and before sleep.
  • Device type: Use validated brachial arm cuffs instead of wrist monitors.

Bookimed Expert Insight: South Korea is a global cardiology hub where institutions like Severance Hospital and Asan Medical Center manage millions of patients. Our data shows a trend toward total digitalization in clinics like Seoul National University Bundang Hospital. For patients, this means home readings are no longer just for personal logs. They are increasingly integrated into digital healthcare systems for real-time specialist review.

Patient Consensus: Patients note that home monitoring reveals white-coat spikes often missed during short clinic visits. Many recommend calibrating your home cuff against the hospital device during your first appointment to ensure accuracy.

What proportion of Korean adults actually have their hypertension controlled?

Recent data shows 62.2% of Korean adults now maintain controlled blood pressure levels. This marks a significant national milestone in cardiovascular health. Rates remain highest among those receiving active medical treatment. Approximately 76% of hypertensive patients currently utilize blood pressure medication.

  • Treatment success: Patients on medication achieve blood pressure control in 72% to 73% of cases.
  • Awareness gap: Around 78.6% of adults are aware they have hypertension before starting treatment.
  • Age disparity: Controlled rates for young adults aged 20–39 drop significantly to 32.9%.
  • Senior outcomes: Adults over 65 years reach control rates approaching 60% through consistent monitoring.

Bookimed Expert Insight: Korea's high control rates correlate with extreme institutional specialization in cardiology. Facilities like Asan Medical Center perform 45% of the country's heart transplants. This concentrated expertise ensures that even complex, resistant hypertension cases benefit from protocols used in high-volume surgical centers. Patients should prioritize clinics with integrated cardiovascular centers for more precise 24-hour monitoring.

Get a free consultation

Select the best way to contact you